Evelo Biosciences, Inc.

Ownership Transactions Reported by 25 Insiders

Symbol
EVLO on OTC
Industry
Pharmaceutical Preparations
Location
124 Washington Street, Suite 101, Foxboro, MA

There are no Buy or Sell transactions made by insiders since 12/17/2023

Evelo Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Flagship Pioneering Fund VII General Partner LLC 10%+ Owner $4.52M May 27, 2022
Flagship Ventures Fund IV General Partner LLC 10%+ Owner $2.62M Jul 11, 2023
Horizon Technology Finance Corp 10%+ Owner $714K Jul 11, 2023
David R. Epstein Director $31K Jun 30, 2022
Mark Bodmer CSO, President of R&D $8.49K Nov 7, 2023
Marella Thorell Chief Financial Officer $7.35K Nov 7, 2023
Simba Gill President & CEO, Director $5.86K Nov 7, 2023
Duncan McHale Chief Medical Officer $5.61K Nov 7, 2023
Mark Plinio Chief Commercial Officer $1.24K Jan 31, 2023
Stephen J. Carriere Principal Accounting Officer $67.00 Jan 19, 2023
Ara Darzi Director Jun 9, 2022
Iain B. McInnes Director Jun 8, 2023
Daniel Char General Counsel Jul 19, 2022
Tonya Williams Director Jun 8, 2023
John Hohneker Director Jun 8, 2023
Alexander C. Reynolds Director Jul 11, 2023
Julie McHugh Director Jun 8, 2023
Jeffrey R. Moore Director Jul 11, 2023
Robert L. Rosiello Director Jun 8, 2023
David P. Perry Director Jun 8, 2021
Jonathan B. Zung Chief Development Officer Jul 19, 2022
Jose-Carlos Gutierrez-Ramos Director Jun 8, 2023
Juan Andres Director Jun 8, 2023
Kyriazi Theo Melas Director Jun 8, 2023
Luca Scavo Cfo Jan 19, 2022

Recent Insider Transactions by Companies or Individuals for Evelo Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.